Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Erlotinib | 0.031623 | uM | 7 | 312.50 | 133.67 | 236.00 | 281.00 | 0.8399 | 0.6995 |
| BT-20 | Lapatinib | 1 | uM | 7 | 312.50 | 133.67 | 172.00 | 281.00 | 0.6121 | 0.2652 |
| BT-20 | 17-AAG | 0.1 | uM | 7 | 312.50 | 133.67 | 118.00 | 281.00 | 0.4199 | -0.1098 |
| BT-20 | Lapatinib | 0.01 | uM | 7 | 312.50 | 133.67 | 302.00 | 281.00 | 1.0747 | 1.1391 |
| BT-20 | 0 | uM | 7 | 312.50 | 133.67 | 241.00 | 281.00 | 0.8577 | 0.7331 | |
| BT-20 | 0 | uM | 7 | 312.50 | 133.67 | 3.00 | 281.00 | 0.0107 | -0.9710 | |
| BT-20 | 0 | uM | 7 | 625.00 | 270.29 | 2.00 | 763.50 | 0.0026 | -0.9622 | |
| BT-20 | 0 | uM | 7 | 625.00 | 270.29 | 753.00 | 763.50 | 0.9863 | 0.9816 | |
| BT-20 | 0 | uM | 7 | 625.00 | 270.29 | 650.00 | 763.50 | 0.8513 | 0.7963 | |
| BT-20 | 17-AAG | 3.1623 | uM | 7 | 625.00 | 270.29 | 255.00 | 763.50 | 0.3340 | -0.0381 |
| BT-20 | Lapatinib | 0.0033113 | uM | 7 | 625.00 | 270.29 | 782.00 | 763.50 | 1.0242 | 1.0322 |
| BT-20 | Lapatinib | 0.031623 | uM | 7 | 625.00 | 270.29 | 713.00 | 763.50 | 0.9339 | 0.9107 |
| BT-20 | 17-AAG | 0.0033113 | uM | 7 | 625.00 | 270.29 | 715.00 | 763.50 | 0.9365 | 0.9143 |
| BT-20 | Linsitinib | 1 | uM | 7 | 625.00 | 270.29 | 651.00 | 763.50 | 0.8527 | 0.7981 |
| BT-20 | Lapatinib | 0.0016596 | uM | 7 | 625.00 | 270.29 | 780.00 | 763.50 | 1.0216 | 1.0287 |
| BT-20 | 0 | uM | 7 | 625.00 | 270.29 | 927.00 | 763.50 | 1.2141 | 1.2766 | |
| BT-20 | Linsitinib | 0.0033113 | uM | 7 | 625.00 | 270.29 | 848.00 | 763.50 | 1.1107 | 1.1452 |
| BT-20 | Linsitinib | 0.1 | uM | 7 | 625.00 | 270.29 | 791.00 | 763.50 | 1.0360 | 1.0478 |
| BT-20 | Lapatinib | 0.31623 | uM | 7 | 625.00 | 270.29 | 980.00 | 763.50 | 1.2836 | 1.3626 |
| BT-20 | Linsitinib | 0.031623 | uM | 7 | 625.00 | 270.29 | 933.00 | 763.50 | 1.2220 | 1.2864 |
| BT-20 | 17-AAG | 10 | uM | 7 | 625.00 | 270.29 | 192.00 | 763.50 | 0.2515 | -0.2041 |
| BT-20 | Lapatinib | 0.1 | uM | 7 | 625.00 | 270.29 | 860.00 | 763.50 | 1.1264 | 1.1654 |
| BT-20 | 17-AAG | 0.31623 | uM | 7 | 625.00 | 270.29 | 269.00 | 763.50 | 0.3523 | -0.0032 |
| BT-20 | Linsitinib | 10 | uM | 7 | 625.00 | 270.29 | 521.00 | 763.50 | 0.6824 | 0.5497 |
| BT-20 | Linsitinib | 0.31623 | uM | 7 | 625.00 | 270.29 | 629.00 | 763.50 | 0.8238 | 0.7573 |